Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts Qtrly Profit Attributable RMB18.9 Million
April 24 (Reuters) - Jilin Province Huinan Changlong
Bio-pharmacy Co Ltd 8049.HK :
* QTRLY TURNOVER RMB160.5 MILLION VERSUS RMB153.1 MILLION
* QTRLY PROFIT ATTRIBUTABLE TO EQUITY HOLDERS RMB18.9
MILLION
VERSUS RMB17.9 MILLION
* ON 24 APRIL 2018, A SPECIAL DIVIDEND OF RMB7 CENTS PER
SHARE WAS
PROPOSED
Source text for Eikon: ID:nHKS40lw3H
Further company coverage: 8049.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jilin Province Huinan Changlong Bio-pharmacy
See all newsJilin Changlong Bio-pharmacy interim profit rises on lower costs
Brief: Jilin Province Huinan Changlong Bio-pharmacy Posts H1 Revenue Of RMB 435 million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Profit For Year Attributable Rmb198.9 Million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Structured Deposit Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Management Product For RMB50 MLN